Mauran, Rolly B.
HRN: 27-90-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/08/2025
10/14/2025
IV
750mg
Q48h
CAP HR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes